Clinical trial
4-aminopyridine Treatment for Nerve Injury Resulting From Radical Retro-Pubic Prostatectomy
NCT03701581 is registered in ClinicalTrials.gov with John Elfar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 4-aminopyridine Treatment for Nerve Injury Resulting From Radical Retro-Pubic Prostatectomy
- Lead sponsor
- John Elfar
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- June 5, 2021
- Completion date
- December 31, 2028
- Enrollment
- 70 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
nerve injury, prostate cancer